Berta Segura-Collar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Mesenchymal Stem Cells

Epidermal Growth Factor Receptor

Top Venues

Science translational medicine

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Berta Segura-Collar, Ricardo Gargini
Sex differences in glioblastoma based on tumor subtypes. Neuro-oncology (2024)
Sara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, Blanca Cómitre-Mariano, Denisse Alcivar-López, Juan M Sepulveda, Aurelio Hernández-Laín, Ángel Pérez-Núñez, Berta Segura-Collar, Ricardo Gargini
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Berta Segura-Collar, Ricardo Gargini
Sex differences in glioblastoma based on tumor subtypes. Neuro-oncology 26 (8) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, C G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Sara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, Blanca Cómitre-Mariano, Denisse Alcivar-López, Juan M Sepulveda, Aurelio Hernández-Laín, Ángel Pérez-Núñez, Berta Segura-Collar, Ricardo Gargini
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Sara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, Blanca Cómitre-Mariano, Denisse Alcivar-López, Juan M Sepulveda, Aurelio Hernández-Laín, Ángel Pérez-Núñez, Berta Segura-Collar, Ricardo Gargini
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma. Neuro-oncology 26 (7) (2024)
Berta Segura-Collar, Ricardo Gargini
Sex differences in glioblastoma based on tumor subtypes. Neuro-oncology 26 (8) (2024)
Berta Segura-Collar, Juan Jiménez-Sanchez, Ricardo Gargini, Miodrag Dragoj, Juan Manuel Sepúlveda Sánchez, Milica Pesic, María A Ramírez, Luis E Ayala-Hernández, Vicente A Torres, Victor M Pérez-García
On optimal temozolomide scheduling for slowly growing glioblastomas. Neuro-oncology advances 4 (1) (2022)
Ricardo Gargini, Berta Segura-Collar, Beatriz Herránz, Vega García-Escudero, Andrés Romero-Bravo, Felipe J Núñez, Daniel García-Pérez, Jacqueline Gutiérrez-Guamán, Angel Ayuso-Sacido, Joan Seoane, Angel Pérez-Nuñez, Juan M Sepúlveda-Sánchez, Aurelio Hernández-Laín, Maria Graciela Castro, Ramon Garcia-Escudero, Jesús Avila, Vicente A Torres
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. Science translational medicine 12 (527) (2021)